Browsing Category

Top Industry News

7091 posts

Novartis Nominates Former BMS CEO & Executive Chairman as New Chair
By

By
Novartis has proposed Dr. Giovanni Caforio, ex-CEO and Executive Chairman of Bristol Myers Squibb, as Chair of the company’s Board of Directors.  The election to decide the next chair of Novartis’…

Lilly To Acquire Injectable Mfg Site From Nexus Pharma
By

By
Eli Lilly and Company has agreed to acquire a manufacturing facility in Pleasant Prairie, Wisconsin, from Nexus Pharmaceuticals, a Lincolnshire, Illinois-based specialty- and generic-drug manufacturer of injectable drugs.   Lilly estimates…

Vertex, TreeFrog Therapeutics in $780-M Pact for Cell-Therapy Mfg
By

By
Vertex Pharmaceuticals, a Boston-based bio/pharmaceutical company, and TreeFrog Therapeutics, a Bordeaux, France-based bio/pharmaceutical company, have formed a collaboration under which Vertex has obtained an exclusive license to TreeFrog’s proprietary cell-manufacturing…

BMS, Cellares in $380-M Deal For CAR-T Cell Therapy Supply & Mfg
By

By
Bristol Myers Squibb (BMS) and Cellares, a South San Francisco, California-based CDMO of cell therapies, have announced a worldwide capacity reservation and supply agreement for the manufacture of BMS’ CAR-T…

Fujifilm Diosynth Biotechnologies Investing $1.2 Bn More In Biomanufacturing Expansion
By

By
Fujifilm Corporation, the parent company of Fujifilm Diosynth Biotechnologies, has announced an additional investment of $1.2 billion to further expand Fujifilm’s Diosynth Biotechnologies biomanufacturing facility in Holly Springs, North Carolina,…

Moderna Pauses Plan for $500-M mRNA Mfg Plant in Kenya 
By

By
Moderna has paused its efforts to build a $500-million mRNA manufacturing facility in Kenya while it determines future demand for mRNA vaccines on the African continent. Moderna announced the plans…

White House Releases Strategy to Strengthen Global Health Security
By

By
The White House launched this week (April 16, 2024), the US Global Health Security Strategy, a five-year plan designed as a  whole-of-government, science-based approach to strengthening global health security.   The…

Supplier News: Asahi Kasei, TriLink & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Axplora, Asahi Kasei Bioprocess, Axolabs, TriLink BioTechnologies, API Innovation Center, Apertus, 89bio, BiBo Biopharma Engineering, Kincell Bio and Imugene.   Chemicals/Chemical API Manufacturing *…

Partnering News: AbbVie, CureVac & More 
By

By
A roundup of bio/pharmaceutical partnering news from AbbVie/Medincell and CureVac/MD Anderson Cancer Center.  * AbbVie, Medincell in $1.9-Bn Injectables Pact* CureVac, MD Anderson Cancer Center in Cancer Vaccine Pact AbbVie,…

Vertex To Acquire Alpine Immune Sciences for $4.9 Bn 
By

By
Vertex Pharmaceuticals, a Boston-based bio/pharmaceutical company, has agreed to acquire Alpine Immune Sciences, a Seattle, Washington-based clinical-stage bio/pharmaceutical company developing protein-based immunotherapies, for approximately $4.9 billion.  Alpine’s lead molecule, povetacicept…